Goldman Sachs
AMYT

Goldman Sachs’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Goldman Sachs’s Portfolio AMYT Stock Details AMYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-163,968
Closed -$2.39M – 6292
2023
Q1 		$2.39M Buy
+163,968
New +$2.32M ﹤0.01% 3724
2022
Q4 		– Sell
-10,609
Closed -$73K – 6411
2022
Q3 		$73K Sell
10,609
-684
-6% -$5.1K ﹤0.01% 5753
2022
Q2 		$79K Sell
11,293
-533
-5% -$4.16K ﹤0.01% 5931
2022
Q1 		$98K Sell
11,826
-3,284
-22% -$29.6K ﹤0.01% 6116
2021
Q4 		$163K Sell
15,110
-11,911
-44% -$129K ﹤0.01% 5977
2021
Q3 		$326K Buy
+27,021
New +$305K ﹤0.01% 5450

Goldman Sachs's AMYT Position: Q2 2023 in Review

Goldman Sachs sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 163,968 shares — an estimated $2.39M sold.

Goldman Sachs first reported a position in AMYT in Q3 2021 and held it in 6 quarters. The position peaked at $2.39M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Goldman Sachs reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Goldman Sachs sold 163,968 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $2.39M.
  • Goldman Sachs first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2021 and held it in 6 quarters.
  • Goldman Sachs's Amryt Pharma plc American Depositary Shares position peaked at $2.39M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.